Don't miss out on an interactive ACC.19 session, Evaluating Disruptive Technology in a Value-Based World, taking place Saturday, March 16 at 12:15 p.m. CT, room 352. This session explores the future of disruptive cardiovascular technologies, examining both the clinical opportunities and fundamental question of assessing value. Its intent is to juxtapose the scientific knowledge against the challenge of assessing utility in a health care environment that is increasingly seeking the value proposition in assessing new approaches to care delivery. Learn more. For more information on all the Late-Breaking Clinical Trials, guideline-focused sessions and keynotes happening at ACC.19, March 16 – 18 in New Orleans, visit ACCScientificSession.ACC.org.